{"id": "6LYTw-YAAAAJ", "citedby": 73654, "citedby5y": 60733, "hindex": 86, "hindex5y": 81, "i10index": 139, "i10index5y": 137, "coauthors": [], "name": "Katherine A. Hoadley", "affiliation": "University of North Carolina at Chapel Hill", "interests": [], "cites_per_year": {"2009": 340, "2010": 578, "2011": 976, "2012": 1731, "2013": 3458, "2014": 4950, "2015": 6747, "2016": 8625, "2017": 10385, "2018": 12095, "2019": 15319, "2020": 7419}, "publications": [{"bib": {"title": "Comprehensive molecular portraits of human breast tumours", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4TOpqqG69KYC", "citedby": "6216"}, {"bib": {"title": "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1", "year": "2010"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:u5HHmVD_uO8C", "citedby": "5070"}, {"bib": {"title": "Comprehensive genomic characterization defines human glioblastoma genes and core pathways", "year": "2008"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ZeXyd9-uunAC", "citedby": "4953"}, {"bib": {"title": "Comprehensive molecular characterization of human colon and rectal cancer", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:qxL8FJ1GzNcC", "citedby": "4131"}, {"bib": {"title": "Integrated genomic analyses of ovarian carcinoma", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:9yKSN-GCB0IC", "citedby": "4098"}, {"bib": {"title": "The cancer genome atlas pan-cancer analysis project", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:-f6ydRqryjwC", "citedby": "2598"}, {"bib": {"title": "The somatic genomic landscape of glioblastoma", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:yB1At4FlUx8C", "citedby": "2576"}, {"bib": {"title": "Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:9ZlFYXVOiuMC", "citedby": "2401"}, {"bib": {"title": "Comprehensive molecular characterization of gastric adenocarcinoma", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:HoB7MX3m0LUC", "citedby": "2317"}, {"bib": {"title": "Comprehensive genomic characterization of squamous cell lung cancers", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:M3ejUd6NZC8C", "citedby": "2260"}, {"bib": {"title": "Integrated genomic characterization of endometrial carcinoma", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_kc_bZDykSQC", "citedby": "2247"}, {"bib": {"title": "Comprehensive molecular profiling of lung adenocarcinoma", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:maZDTaKrznsC", "citedby": "2133"}, {"bib": {"title": "Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma", "year": "2010"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:u-x6o8ySG0sC", "citedby": "1925"}, {"bib": {"title": "Comprehensive molecular characterization of clear cell renal cell carcinoma", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:dhFuZR0502QC", "citedby": "1896"}, {"bib": {"title": "Comprehensive molecular characterization of urothelial bladder carcinoma", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:M05iB0D1s5AC", "citedby": "1499"}, {"bib": {"title": "Comprehensive genomic characterization of head and neck squamous cell carcinomas", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_axFR9aDTf0C", "citedby": "1394"}, {"bib": {"title": "Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:yD5IFk8b50cC", "citedby": "1365"}, {"bib": {"title": "Genomic classification of cutaneous melanoma", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:XD-gHx7UXLsC", "citedby": "1146"}, {"bib": {"title": "Integrated genomic characterization of papillary thyroid carcinoma", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:O3NaXMp0MMsC", "citedby": "1137"}, {"bib": {"title": "The molecular taxonomy of primary prostate cancer", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:dfsIfKJdRG4C", "citedby": "1087"}, {"bib": {"title": "Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:k_IJM867U9cC", "citedby": "947"}, {"bib": {"title": "Comprehensive molecular portraits of invasive lobular breast cancer", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:fPk4N6BV_jEC", "citedby": "882"}, {"bib": {"title": "Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:9Nmd_mFXekcC", "citedby": "877"}, {"bib": {"title": "Comprehensive molecular characterization of muscle-invasive bladder cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:7T2F9Uy0os0C", "citedby": "637"}, {"bib": {"title": "The immune landscape of cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:k8Z6L05lTy4C", "citedby": "612"}, {"bib": {"title": "Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:u_35RYKgDlwC", "citedby": "579"}, {"bib": {"title": "Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:eQOLeE2rZwMC", "citedby": "563"}, {"bib": {"title": "Comprehensive characterization of cancer driver genes and mutations", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:VaXvl8Fpj5cC", "citedby": "560"}, {"bib": {"title": "Comprehensive and integrative genomic characterization of hepatocellular carcinoma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:N5tVd3kTz84C", "citedby": "540"}, {"bib": {"title": "Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hFOr9nPyWt4C", "citedby": "493"}, {"bib": {"title": "The somatic genomic landscape of chromophobe renal cell carcinoma", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:SeFeTyx0c_EC", "citedby": "483"}, {"bib": {"title": "Oncogenic signaling pathways in the cancer genome atlas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:oNZyr7d5Mn4C", "citedby": "454"}, {"bib": {"title": "SomaticSniper: identification of somatic point mutations in whole genome sequencing data", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:IWHjjKOFINEC", "citedby": "441"}, {"bib": {"title": "TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ufrVoPGSRksC", "citedby": "428"}, {"bib": {"title": "Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:uWQEDVKXjbEC", "citedby": "423"}, {"bib": {"title": "Integrated genomic characterization of oesophageal carcinoma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:geHnlv5EZngC", "citedby": "407"}, {"bib": {"title": "Prognostically relevant gene signatures of high-grade serous ovarian carcinoma", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:3fE2CSJIrl8C", "citedby": "403"}, {"bib": {"title": "Integrated genomic characterization of pancreatic ductal adenocarcinoma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:UHK10RUVsp4C", "citedby": "395"}, {"bib": {"title": "Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:M7yex6snE4oC", "citedby": "391"}, {"bib": {"title": "An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:MLfJN-KU85MC", "citedby": "348"}, {"bib": {"title": "Integrated genomic and molecular characterization of cervical cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5ugPr518TE4C", "citedby": "304"}, {"bib": {"title": "Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5awf1xo2G04C", "citedby": "288"}, {"bib": {"title": "EGFR associated expression profiles vary with breast tumor subtype", "year": "2007"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:d1gkVwhDpl0C", "citedby": "284"}, {"bib": {"title": "Comprehensive pan-genomic characterization of adrenocortical carcinoma", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:rO6llkc54NcC", "citedby": "278"}, {"bib": {"title": "Integrative analysis identifies four molecular and clinical subsets in uveal melanoma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:JQOojiI6XY0C", "citedby": "250"}, {"bib": {"title": "Comprehensive and integrated genomic characterization of adult soft tissue sarcomas", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:fEOibwPWpKIC", "citedby": "227"}, {"bib": {"title": "Characterization of HPV and host genome interactions in primary head and neck cancers", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:JV2RwH3_ST0C", "citedby": "226"}, {"bib": {"title": "MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:UxriW0iASnsC", "citedby": "218"}, {"bib": {"title": "Joint and individual variation explained (JIVE) for integrated analysis of multiple data types", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:roLk4NBRz8UC", "citedby": "218"}, {"bib": {"title": "Comprehensive molecular characterization of pheochromocytoma and paraganglioma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:eJXPG6dFmWUC", "citedby": "216"}, {"bib": {"title": "Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus \u2026", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4OULZ7Gr8RgC", "citedby": "204"}, {"bib": {"title": "Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types", "year": "2010"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:WF5omc3nYNoC", "citedby": "203"}, {"bib": {"title": "Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:J-pR_7NvFogC", "citedby": "202"}, {"bib": {"title": "Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:i2xiXl-TujoC", "citedby": "197"}, {"bib": {"title": "Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:RHpTSmoSYBkC", "citedby": "195"}, {"bib": {"title": "Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:KlAtU1dfN6UC", "citedby": "190"}, {"bib": {"title": "Machine learning identifies stemness features associated with oncogenic dedifferentiation", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:lmc2jWPfTJgC", "citedby": "189"}, {"bib": {"title": "Cell-type-specific responses to chemotherapeutics in breast cancer", "year": "2004"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:2osOgNQ5qMEC", "citedby": "187"}, {"bib": {"title": "The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:vbGhcppDl1QC", "citedby": "178"}, {"bib": {"title": "Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:EYYDruWGBe4C", "citedby": "174"}, {"bib": {"title": "Pathogenic germline variants in 10,389 adult cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:LI9QrySNdTsC", "citedby": "171"}, {"bib": {"title": "RNA expression analysis of formalin-fixed paraffin-embedded tumors", "year": "2007"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:qjMakFHDy7sC", "citedby": "170"}, {"bib": {"title": "Spectrum of somatic mitochondrial mutations in five cancers", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:b0M2c_1WBrUC", "citedby": "168"}, {"bib": {"title": "miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_FxGoFyzp5QC", "citedby": "159"}, {"bib": {"title": "Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4MWp96NkSFoC", "citedby": "153"}, {"bib": {"title": "Genomic and functional approaches to understanding cancer aneuploidy", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:b1wdh0AR-JQC", "citedby": "152"}, {"bib": {"title": "Gene expression patterns associated with p53 status in breast cancer", "year": "2006"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:IjCSPb-OGe4C", "citedby": "152"}, {"bib": {"title": "Comprehensive analysis of alternative splicing across tumors from 8,705 patients", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kh2fBNsKQNwC", "citedby": "151"}, {"bib": {"title": "Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ML0RJ9NH7IQC", "citedby": "142"}, {"bib": {"title": "The chromatin accessibility landscape of primary human cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:HtEfBTGE9r8C", "citedby": "138"}, {"bib": {"title": "Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:OU6Ihb5iCvQC", "citedby": "138"}, {"bib": {"title": "Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:j3f4tGmQtD8C", "citedby": "136"}, {"bib": {"title": "lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kuK5TVdYjLIC", "citedby": "134"}, {"bib": {"title": "A comprehensive pan-cancer molecular study of gynecologic and breast cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:p__nRnzSRKYC", "citedby": "128"}, {"bib": {"title": "Integrated molecular characterization of uterine carcinosarcoma", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:wbdj-CoPYUoC", "citedby": "125"}, {"bib": {"title": "Driver fusions and their implications in the development and treatment of human cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:g3aElNc5_aQC", "citedby": "119"}, {"bib": {"title": "Genomic analysis of immune cell infiltrates across 11 tumor types", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:XiSMed-E-HIC", "citedby": "116"}, {"bib": {"title": "Bladder cancer molecular taxonomy: summary from a consensus meeting", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:bFI3QPDXJZMC", "citedby": "116"}, {"bib": {"title": "Perspective on oncogenic processes at the end of the beginning of cancer genomics", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kz9GbA2Ns4gC", "citedby": "106"}, {"bib": {"title": "Comparative molecular analysis of gastrointestinal adenocarcinomas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:gsN89kCJA0AC", "citedby": "104"}, {"bib": {"title": "Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:NhqRSupF_l8C", "citedby": "101"}, {"bib": {"title": "The molecular diversity of Luminal A breast tumors", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hC7cP41nSMkC", "citedby": "100"}, {"bib": {"title": "Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hMsQuOkrut0C", "citedby": "95"}, {"bib": {"title": "Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:L7CI7m0gUJcC", "citedby": "95"}, {"bib": {"title": "Integrated molecular characterization of testicular germ cell tumors", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:xtoqd-5pKcoC", "citedby": "92"}, {"bib": {"title": "In vitro and in vivo analysis of B-Myb in basal-like breast cancer", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:W7OEmFMy1HYC", "citedby": "86"}, {"bib": {"title": "Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:UebtZRa9Y70C", "citedby": "83"}, {"bib": {"title": "Integrative molecular characterization of malignant pleural mesothelioma", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:0izLItjtcgwC", "citedby": "81"}, {"bib": {"title": "Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Women\u2019s Hospital; Broad Institute; Brown University; Case Western Reserve University; Dana-Farber Cancer \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5icHVeHT4IsC", "citedby": "80"}, {"bib": {"title": "Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:f2IySw72cVMC", "citedby": "80"}, {"bib": {"title": "Albert Einstein College of Medicine; Analytical Biological Services; Barretos Cancer Hospital; Baylor College of Medicine; Beckman Research Institute of City of Hope", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:8xutWZnSdmoC", "citedby": "78"}, {"bib": {"title": "Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:pyW8ca7W8N0C", "citedby": "78"}, {"bib": {"title": "Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:r_AWSJRzSzQC", "citedby": "76"}, {"bib": {"title": "Genomic, pathway network, and immunologic features distinguishing squamous carcinomas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:KUbvn5osdkgC", "citedby": "75"}, {"bib": {"title": "Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ye4kPcJQO24C", "citedby": "74"}, {"bib": {"title": "An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:D03iK_w7-QYC", "citedby": "73"}, {"bib": {"title": "Integrated RNA and DNA sequencing improves mutation detection in low purity tumors", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:r0BpntZqJG4C", "citedby": "72"}, {"bib": {"title": "Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The Cancer Genome Atlas Pan-Cancer analysis project", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:dBIO0h50nwkC", "citedby": "69"}, {"bib": {"title": "A pan-cancer analysis of enhancer expression in nearly 9000 patient samples", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tuHXwOkdijsC", "citedby": "68"}, {"bib": {"title": "Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tS2w5q8j5-wC", "citedby": "67"}, {"bib": {"title": "An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:zYLM7Y9cAGgC", "citedby": "66"}, {"bib": {"title": "Correction: Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:gKiMpY-AVTkC", "citedby": "65"}, {"bib": {"title": "Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy", "year": "2010"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Y0pCki6q_DkC", "citedby": "65"}, {"bib": {"title": "The integrated genomic landscape of thymic epithelial tumors", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ipzZ9siozwsC", "citedby": "64"}, {"bib": {"title": "Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis", "year": "2007"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:YsMSGLbcyi4C", "citedby": "60"}, {"bib": {"title": "A consensus molecular classification of muscle-invasive bladder cancer", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:P7Ujq4OLJYoC", "citedby": "56"}, {"bib": {"title": "Systematic analysis of splice-site-creating mutations in cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:TIZ-Mc8IlK0C", "citedby": "56"}, {"bib": {"title": "Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer", "year": "2010"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:LkGwnXOMwfcC", "citedby": "50"}, {"bib": {"title": "The molecular basis of breast cancer pathological phenotypes", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tOudhMTPpwUC", "citedby": "49"}, {"bib": {"title": "Comprehensive molecular characterization of the Hippo signaling pathway in cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:a9-T7VOCCH8C", "citedby": "46"}, {"bib": {"title": "Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tYavs44e6CUC", "citedby": "45"}, {"bib": {"title": "Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ILKRHgRFtOwC", "citedby": "44"}, {"bib": {"title": "Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ZuybSZzF8UAC", "citedby": "41"}, {"bib": {"title": "Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:M3NEmzRMIkIC", "citedby": "40"}, {"bib": {"title": "Tumor mutational burden is a determinant of immune-mediated survival in breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Ri6SYOTghG4C", "citedby": "39"}, {"bib": {"title": "Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:dQ2og3OwTAUC", "citedby": "39"}, {"bib": {"title": "A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-\u03b2 superfamily", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:LO7wyVUgiFcC", "citedby": "36"}, {"bib": {"title": "Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:epqYDVWIO7EC", "citedby": "36"}, {"bib": {"title": "Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:iH-uZ7U-co4C", "citedby": "36"}, {"bib": {"title": "Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines", "year": "2004"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Tyk-4Ss8FVUC", "citedby": "33"}, {"bib": {"title": "Integrated genomic analysis of the ubiquitin pathway across cancer types", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:BwyfMAYsbu0C", "citedby": "31"}, {"bib": {"title": "Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4fGpz3EwCPoC", "citedby": "26"}, {"bib": {"title": "Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:l7t_Zn2s7bgC", "citedby": "26"}, {"bib": {"title": "Gene expression signatures in pre-and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or \u2026", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:bEWYMUwI8FkC", "citedby": "26"}, {"bib": {"title": "DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:dshw04ExmUIC", "citedby": "23"}, {"bib": {"title": "Carcinoma of unknown primary site.", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:BqipwSGYUEgC", "citedby": "22"}, {"bib": {"title": "Abstract S4-05: Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after \u2026", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:70eg2SAEIzsC", "citedby": "21"}, {"bib": {"title": "Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:SdhP9T11ey4C", "citedby": "20"}, {"bib": {"title": "BreakTrans: uncovering the genomic architecture of gene fusions", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:qUcmZB5y_30C", "citedby": "19"}, {"bib": {"title": "Potential Predictive Markers of Benefit from Cetuximab in Metastatic Breast Cancer: An Analysis of Two Randomized Phase 2 Trials.", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:QIV2ME_5wuYC", "citedby": "19"}, {"bib": {"title": "Intratumor heterogeneity of the estrogen receptor and the long-term risk of fatal breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:t7zJ5fGR-2UC", "citedby": "18"}, {"bib": {"title": "Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:uc_IGeMz5qoC", "citedby": "17"}, {"bib": {"title": "Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:VOx2b1Wkg3QC", "citedby": "17"}, {"bib": {"title": "Integrated analysis of RNA and DNA from the phase III trial CALGB 40601 identifies predictors of response to trastuzumab-based neoadjuvant chemotherapy in HER2-positive breast \u2026", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:YohjEiUPhakC", "citedby": "16"}, {"bib": {"title": "Nuclear localized LSR: a novel regulator of breast cancer behavior and tumorigenesis", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:08ZZubdj9fEC", "citedby": "14"}, {"bib": {"title": "Identification of mRNA isoform switching in breast cancer", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:P5F9QuxV20EC", "citedby": "13"}, {"bib": {"title": "Proteomic profiling of patient\u2010derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ns9cj8rnVeAC", "citedby": "12"}, {"bib": {"title": "TCGA Research Network", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:sJsF-0ZLhtgC", "citedby": "12"}, {"bib": {"title": "Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:bnK-pcrLprsC", "citedby": "11"}, {"bib": {"title": "Abstract S6-01: BRCA1 methylation status, silencing and treatment effect in the TNT trial: a randomized phase III trial of carboplatin compared with docetaxel for patients with \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:D_sINldO8mEC", "citedby": "9"}, {"bib": {"title": "Prognostic value of B cells in cutaneous melanoma", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:a3BOlSfXSfwC", "citedby": "8"}, {"bib": {"title": "FOXM1 deubiquitination by USP21 regulates cell cycle progression and paclitaxel sensitivity in basal-like breast cancer", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:fFSKOagxvKUC", "citedby": "8"}, {"bib": {"title": "TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ruyezt5ZtCIC", "citedby": "8"}, {"bib": {"title": "Genomic basis for RNA alterations revealed by whole-genome analyses of 27 cancer types", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_Ybze24A_UAC", "citedby": "8"}, {"bib": {"title": "Comprehensive molecular characterization and analysis of muscle-invasive urothelial carcinomas.", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:VL0QpB8kHFEC", "citedby": "8"}, {"bib": {"title": "Genomic basis for RNA alterations in cancer", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:buQ7SEKw-1sC", "citedby": "7"}, {"bib": {"title": "Before and after: Comparison of legacy and harmonized TCGA genomic data commons\u2019 data", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:GFxP56DSvIMC", "citedby": "7"}, {"bib": {"title": "Tumor mutational landscape is a record of the pre-malignant state", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:OTTXONDVkokC", "citedby": "7"}, {"bib": {"title": "Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy.", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:PELIpwtuRlgC", "citedby": "7"}, {"bib": {"title": "Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:uJ-U7cs_P_0C", "citedby": "6"}, {"bib": {"title": "Abstract S3-06: Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2 \u2026", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:35N4QoGY0k4C", "citedby": "6"}, {"bib": {"title": "The Immune Microenvironment in Hormone Receptor\u2013Positive Breast Cancer Before and After Preoperative Chemotherapy", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:yqoGN6RLRZoC", "citedby": "5"}, {"bib": {"title": "National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:FPJr55Dyh1AC", "citedby": "5"}, {"bib": {"title": "A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer \u201cBRCAness\u201d subgroups: the TNT Trial", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:-FonjvnnhkoC", "citedby": "5"}, {"bib": {"title": "Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:NyGDZy8z5eUC", "citedby": "4"}, {"bib": {"title": "Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:OP4eGU-M3BUC", "citedby": "4"}, {"bib": {"title": "PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:IRz6iEL74y4C", "citedby": "4"}, {"bib": {"title": "The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4hFrxpcac9AC", "citedby": "4"}, {"bib": {"title": "Multiple myeloma: family history and mortality in second primary cancers", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:PoWvk5oyLR8C", "citedby": "4"}, {"bib": {"title": "Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:pqnbT2bcN3wC", "citedby": "4"}, {"bib": {"title": "Genomic basis for RNA alterations in cancer.", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:BzfGm06jWhQC", "citedby": "3"}, {"bib": {"title": "Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:mlAyqtXpCwEC", "citedby": "3"}, {"bib": {"title": "A comprehensive analysis of fusion transcripts in breast cancer reveals associations between number of fusion transcripts, copy number events, gene expression profiles, and \u2026", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5Ul4iDaHHb8C", "citedby": "3"}, {"bib": {"title": "Comprehensive characterization of 412 muscle invasive urothelial carcinomas: Final analysis of The Cancer Genome Atlas (TCGA) project.", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:KxtntwgDAa4C", "citedby": "3"}, {"bib": {"title": "Van\u2019t Veer LJ, Lopez-Bigas N., Laird PW, Raphael BJ, Ding L., Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C., Chen Z., Collisson EA Cancer Genome Atlas Research \u2026", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:F1b5ZUV5XREC", "citedby": "3"}, {"bib": {"title": "van RN, Hogue LA, Cannon CL, Buchman TG, Hotchkiss RS, Coopersmith CM: Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance", "year": "2008"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:artPoR2Yc-kC", "citedby": "3"}, {"bib": {"title": "vasn Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, & Paul KD: An informational intensive approach to the \u2026", "year": "1997"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:RGFaLdJalmkC", "citedby": "3"}, {"bib": {"title": "Proteogenomic Characterization of Endometrial Carcinoma", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:lgwcVrK6X84C", "citedby": "2"}, {"bib": {"title": "Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_OXeSy2IsFwC", "citedby": "2"}, {"bib": {"title": "Androgen receptor mRNA expression in urothelial carcinoma of the bladder: A retrospective analysis of two independent cohorts", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:3htObqc8RwsC", "citedby": "2"}, {"bib": {"title": "Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:BrmTIyaxlBUC", "citedby": "2"}, {"bib": {"title": "Progress in The Cancer Genome Atlas bladder cancer project", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:3s1wT3WcHBgC", "citedby": "2"}, {"bib": {"title": "Abstract S2-04: Comprehensive molecular characterization of invasive lobular breast tumors", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:2P1L_qKh6hAC", "citedby": "2"}, {"bib": {"title": "Correction: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:HeT0ZceujKMC", "citedby": "2"}, {"bib": {"title": "Virus expression detection reveals RNA-sequencing contamination in TCGA", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:QD3KBmkZPeQC", "citedby": "1"}, {"bib": {"title": "Comprehensive analysis of genetic ancestry and its molecular correlates in cancer", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:U4n9YNQMCAIC", "citedby": "1"}, {"bib": {"title": "Abstract GS3-08: Multiplatform analysis of matched primary and metastatic breast tumors from the AURORA US Network", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:48xauSegjOkC", "citedby": "1"}, {"bib": {"title": "Genetic determinants of the molecular portraits of epithelial cancers", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:uDGL6kOW6j0C", "citedby": "1"}, {"bib": {"title": "Joint and individual analysis of breast cancer histologic images and genomic covariates", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:PVgj2kMGcgYC", "citedby": "1"}, {"bib": {"title": "174O Predictive and prognostic value of B-cell gene-expression signatures and B-cell receptor (BCR) repertoire in HER2+ breast cancer: A correlative analysis of the CALGB 40601 \u2026", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5MTHONV0fEkC", "citedby": "1"}, {"bib": {"title": "Genomic-based predictive biomarkers to anti-HER2 therapies: A combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials.", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:F9fV5C73w3QC", "citedby": "1"}, {"bib": {"title": "Abstract LB-373: Comprehensive analysis of cancer stemness", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:86PQX7AUzd4C", "citedby": "1"}, {"bib": {"title": "The molecular landscape of oncogenic signaling pathways in The Cancer Genome Atlas", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5qfkUJPXOUwC", "citedby": "1"}, {"bib": {"title": "Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4JMBOYKVnBMC", "citedby": "1"}, {"bib": {"title": "Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:EkHepimYqZsC", "citedby": "1"}, {"bib": {"title": "Integrated analysis of RNA and DNA from a phase III trial of trastuzumab-based neoadjuvant chemotherapy identifies response predictors in HER2-positive breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:umqufdRvDiIC", "citedby": "1"}, {"bib": {"title": "3 Morphological and Molecular Classification of Human Cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:j8SEvjWlNXcC", "citedby": "1"}, {"bib": {"title": "Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases.", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:8AbLer7MMksC", "citedby": "1"}, {"bib": {"title": "Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tkaPQYYpVKoC", "citedby": "1"}, {"bib": {"title": "Integrated molecular characterization of pheochromocytoma and paraganglioma including a novel, recurrent and prognostic fusion gene", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:fQNAKQ3IYiAC", "citedby": "1"}, {"bib": {"title": "Integrated molecular characterization of uterine carcinosarcoma in The Cancer Genome Atlas (TCGA) project", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:K3LRdlH-MEoC", "citedby": "1"}, {"bib": {"title": "Abstract SY12-03: Multi-tumor analysis of TCGA data identifies expression commonalities across tumor types.", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:TQgYirikUcIC", "citedby": "1"}, {"bib": {"title": "Detecting patient mutomes by integrating DNA and RNA sequencing", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "Reproducible gene expression subtypes of glioblastoma show associations with chromosomal aberrations, gene mutations, and clinical phenotypes", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:u9iWguZQMMsC", "citedby": "1"}, {"bib": {"title": "Identification of drug targets for the treatment of Basal-like tumors", "year": "2005"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Se3iqnhoufwC", "citedby": "1"}, {"bib": {"title": "Concordance of intrinsic subtyping using data from Prosigna (R) and research-based RNA-sequencing of tissue in Triple Negative Breast Cancer Trial (TNT)", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ubry08Y2EpUC", "citedby": "0"}, {"bib": {"title": "Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go \u2026", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:otzGkya1bYkC", "citedby": "0"}, {"bib": {"title": "Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:1lhNe0rCu4AC", "citedby": "0"}, {"bib": {"title": "Abstract P4-05-12: Genetic determinants of the molecular portraits of epithelial cancers", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ALROH1vI_8AC", "citedby": "0"}, {"bib": {"title": "Bidimensional linked matrix factorization for pan-omics pan-cancer analysis", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:CaZNVDsoPx4C", "citedby": "0"}, {"bib": {"title": "A Pan-Cancer and Polygenic Bayesian Hierarchical Model for the Effect of Somatic Mutations on Survival", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:nVrZBo8bIpAC", "citedby": "0"}, {"bib": {"title": "Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4xDN1ZYqzskC", "citedby": "0"}, {"bib": {"title": "In silico APC/C substrate discovery reveals cell cycle degradation of chromatin regulators including UHRF1", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:zCSUwVk65WsC", "citedby": "0"}, {"bib": {"title": "An approach for normalization and quality control for NanoString RNA expression data", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:jgBuDB5drN8C", "citedby": "0"}, {"bib": {"title": "Using RNA Sequencing to Characterize the Tumor Microenvironment", "year": "2020"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:fbc8zXXH2BUC", "citedby": "0"}, {"bib": {"title": "FFPE Sequencing and Bioinformatics", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:wMgC3FpKEyYC", "citedby": "0"}, {"bib": {"title": "Resolving medulloblastoma cellular architecture by single-cell genomics", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:gVv57TyPmFsC", "citedby": "0"}, {"bib": {"title": "The premalignant state captured in the landscape of somatic mutations can reveal the cancer cell-of-origin", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Ehil0879vHcC", "citedby": "0"}, {"bib": {"title": "Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid", "year": "2019"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:KbBQZpvPDL4C", "citedby": "0"}, {"bib": {"title": "Re: Impact of Molecular Subtypes in Muscle-Invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:WJVC3Jt7v1AC", "citedby": "0"}, {"bib": {"title": "Comprehensive characterization of cancer driver genes and mutations", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:bz8QjSJIRt4C", "citedby": "0"}, {"bib": {"title": "Functional and therapeutic significance of ESR1 gene fusions in breast cancer", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hCrLmN-GePgC", "citedby": "0"}, {"bib": {"title": "A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-\u03b2 pathway", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ClCfbGk0d_YC", "citedby": "0"}, {"bib": {"title": "R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:foquWX3nUaYC", "citedby": "0"}, {"bib": {"title": "Comparison of Pre-Processing Methods to Compute PAM50 Intrinsic Subtype in Breast Cancer and Histologically Normal Tumor-Adjacent Regions", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:S16KYo8Pm5AC", "citedby": "0"}, {"bib": {"title": "Abstract P3-16-01: Using the new pan-cancer clinical data resource (TCGA-CDR) to identify breast cancer genomic correlates associating with different survival outcome endpoints", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "Using the new pan-cancer clinical data resource (TCGA-CDR) to identify breast cancer genomic correlates associating with different survival outcome endpoints", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS \u2026", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:jL-93Qbq4QoC", "citedby": "0"}, {"bib": {"title": "A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-? Superfamily.", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:nZcligLrVowC", "citedby": "0"}, {"bib": {"title": "Analysis of androgen receptor mRNA expression in urothelial carcinoma of the bladder", "year": "2018"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:uWiczbcajpAC", "citedby": "0"}, {"bib": {"title": "Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:z_wVstp3MssC", "citedby": "0"}, {"bib": {"title": "Non-Coding RNA modulate molecular subtype biology in muscle invasive bladder cancer (MIBC) and are independently associated with survival", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ZfRJV9d4-WMC", "citedby": "0"}, {"bib": {"title": "Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification (TNBCtype-4)", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "186PBreast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:NJ774b8OgUMC", "citedby": "0"}, {"bib": {"title": "162PDPathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann\u2019s refined classification (TNBCtype-4)", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "Comprehensive Characterization of Genomic, Transcriptomic and Epigenomic Artifacts Introduced in Formalin-Fixed, Paraffin-Embedded Tissues", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Bedeutung der ERBB-Rezeptorfamilie beim Urothelkarzinom der Harnblase: mRNA-Expression und prognostische Relevanz", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "Abstract SY10-02: Pan-cancer study of recurrent and heterogeneous RNA aberrations and association with whole-genome variants", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:PR6Y55bgFSsC", "citedby": "0"}, {"bib": {"title": "Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:1yQoGdGgb4wC", "citedby": "0"}, {"bib": {"title": "User menu", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:V3AGJWp-ZtQC", "citedby": "0"}, {"bib": {"title": "Abstract PD7-02: Identification of breast cancers with an indolent disease course: 70 gene indolent threshold validation in a Swedish randomized trial of tamoxifen vs. not \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kRWSkSYxWN8C", "citedby": "0"}, {"bib": {"title": "Abstract PD2-03: Recurrent functionally diverse in-frame ESR1 gene fusions drive endocrine resistance in breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:mvPsJ3kp5DgC", "citedby": "0"}, {"bib": {"title": "Abstract PD8-01: Race and age differences in PAM50 biomarker status in the Carolina breast cancer study", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:q3oQSFYPqjQC", "citedby": "0"}, {"bib": {"title": "Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:eflP2zaiRacC", "citedby": "0"}, {"bib": {"title": "Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or \u2026", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Integrated genomic and molecular characterization of cervical cancer", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:4X0JR2_MtJMC", "citedby": "0"}, {"bib": {"title": "Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases (vol 13, e1002174, 2016)", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "\u5e94\u7528 MRI Radiomics \u7279\u5f81\u9884\u6d4b\u4e73\u817a\u764c\u590d\u53d1\u98ce\u9669: \u9075\u5faa MammaPrint, Oncotype DX \u548c PAM50 \u7684\u57fa\u56e0\u68c0\u6d4b\u7248\u672c", "year": "2017"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:1qzjygNMrQYC", "citedby": "0"}, {"bib": {"title": "Abstract B21: Integrated genomic characterization of pancreatic ductal adenocarcinoma and the confounding role of purity", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:B3FOqHPlNUQC", "citedby": "0"}, {"bib": {"title": "Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:vRqMK49ujn8C", "citedby": "0"}, {"bib": {"title": "Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:q3CdL3IzO_QC", "citedby": "0"}, {"bib": {"title": "Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:738O_yMBCRsC", "citedby": "0"}, {"bib": {"title": "Molecular analyses of histopathologic morphologic features in breast cancer", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:WbkHhVStYXYC", "citedby": "0"}, {"bib": {"title": "Molecular analyses of histopathologic morphologic features in breast cancer", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:nrtMV_XWKgEC", "citedby": "0"}, {"bib": {"title": "Identification of mRNA isoform switching in breast cancer", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:2tRrZ1ZAMYUC", "citedby": "0"}, {"bib": {"title": "787 The Cancer Genome Atlas (TCGA) project analysis of micro-RNA and gene expression subtypes of high-grade, muscle-invasive urothelial carcinoma", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:tzM49s52ZIMC", "citedby": "0"}, {"bib": {"title": "Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "Abstract S4-02: A comprehensive analysis of fusion transcripts in breast cancer reveals associations between number of fusion transcripts, copy number events, gene expression \u2026", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Abstract S4-01: Identification of early versus late drivers of breast tumors and metastasis", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "Comprehensive Molecular Characterization of 412 Muscle Invasive Urothelial Carcinomas of the Bladder-Final Analysis of The Cancer Genome Atlas (TCGA) Project", "year": "2016"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:xtRiw3GOFMkC", "citedby": "0"}, {"bib": {"title": "Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:eMMeJKvmdy0C", "citedby": "0"}, {"bib": {"title": "Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "Abstract 2435A: Identification and treatment data of xenografts representing TCGA-defined glioblastoma subtypes", "year": "2015"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:zA6iFVUQeVQC", "citedby": "0"}, {"bib": {"title": "Establishment, identification and treatment data of TCGA glioblatoma xenograft subtypes", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "Thousands of published cancer signatures and pathways can be collapsed into a handful of non-redundant gene programs: a TCGA pan-cancer analysis", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hMod-77fHWUC", "citedby": "0"}, {"bib": {"title": "Comprehensive characterization of urothelial bladder cancer: a TCGA Project update", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:blknAaTinKkC", "citedby": "0"}, {"bib": {"title": "Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project.", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:NaGl4SEjCO4C", "citedby": "0"}, {"bib": {"title": "Erratum: Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes (PLoS ONE (2014) 9: 1", "year": "2014"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:yMeIxYmEMEAC", "citedby": "0"}, {"bib": {"title": "Abstract S4-01: An integrated genomics approach identifies novel drivers of oncogenic pathway activity in human breast cancer", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Abstract P4-04-16: Highly variably expressed exons (HVEE) of cancer genes and survival disparity in human breast cancer", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "Abstract A039: The role of long noncoding RNAs in epithelial to mesenchymal transition and cancer stem cells", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Whole exome and whole genome sequence analysis of lung adenocarcinoma.", "year": "2013"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:abG-DnoFyZgC", "citedby": "0"}, {"bib": {"title": "Abstract S6-1: Exploration of isoform switching and mutation expression in breast cancer by mRNA-sequencing analysis", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect", "year": "2012"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ULOm3_A8WrAC", "citedby": "0"}, {"bib": {"title": "OM-06. MIR-181D: A PREDICTIVE GLIOBLASTOMA BIOMARKER THAT DOWNREGULATES MGMT EXPRESSION", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "-OMICS AND PROGNOSTIC MARKERS", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:8k81kl-MbHgC", "citedby": "0"}, {"bib": {"title": "Erratum to: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Zph67rFs4hoC", "citedby": "0"}, {"bib": {"title": "Comparing the Intrinsic Tumor Subtype of Invasive and In-Situ Components of Breast Carcinoma: Analysis of 34 Tumors Using the PAM50 RT-PCR Assay", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:aqlVkmm33-oC", "citedby": "0"}, {"bib": {"title": "An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer (vol 11, pg r55, 2009)", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy", "year": "2011"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:0EnyYjriUFMC", "citedby": "0"}, {"bib": {"title": "Abstract# 1442: Reproducible gene expression subtypes of glioblastoma show associations with chromosomal aberrations, gene mutations, and clinical phenotypes", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:lSLTfruPkqcC", "citedby": "0"}, {"bib": {"title": "An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:mNrWkgRL2YcC", "citedby": "0"}, {"bib": {"title": "Molecular Signatures of Drug Resistance", "year": "2009"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:kNdYIx-mwKoC", "citedby": "0"}, {"bib": {"title": "Parallel microRNA and gene expression profiling of human glioblastomas", "year": "2008"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:RYcK_YlVTxYC", "citedby": "0"}, {"bib": {"title": "The plasminogen-plasmin system in malignancy.", "year": "2008"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:SpbeaW3--B0C", "citedby": "0"}, {"bib": {"title": "Development of Biologically Based Therapies for Basal-Like Tumors", "year": "2007"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:MXK_kJrjxJIC", "citedby": "0"}, {"bib": {"title": "Immuno Tandem Mass Spectrometry(iMASS 2) Assay for Clinical Proteomics: Development and Application of iMASS 2 for EGFR Diagnosis", "year": "2007"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "Development of Biologically Based Therapies for Basal-like Breast Tumors", "year": "2006"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:YOwf2qJgpHMC", "citedby": "0"}, {"bib": {"title": "Identification of targeted therapies for basal-like breast tumors", "year": "2006"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:5nxA0vEk-isC", "citedby": "0"}, {"bib": {"title": "Molecular Heterogeneity of Triple Negative Breast Cancer"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "Article Summary: The Cancer Genome Atlas (TCGA) Bladder Cancer Update"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:0N-VGjzr574C", "citedby": "0"}, {"bib": {"title": "The Cancer Genome Atlas (TCGA) Bladder Cancer Update"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:2KloaMYe4IUC", "citedby": "0"}, {"bib": {"title": "Basic and Translational Investigations"}, "source": "citations", "id_citations": "6LYTw-YAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}]}